Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127249) titled 'Analysis of Clinicopathological Characteristics and Expression of Relevant Therapeutic Targets in Epstein-Barr Virus-Associated Gastric Cancer' on June 28.
Study Type: Observational study
Study Design:
Case-Control study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Epstein-Barr virus (EBV)-associated gastric cancer
Intervention:
EBV?associated gastric cancer group (EBVaGC group):None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-01
Target Sample Size: EBV?associated gastric cancer group (EBVaGC group):42;EBV?negative gastric cancer gro...